|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 601 13th Street NW |
Address2 | Suite 290 North |
| City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400693064-253
|
||||||||
|
6. House ID# 415240024
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Melanie Nathanson |
Date | 12/29/2024 11:21:15 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for Medicare, Medicaid and Marketplace programs, 340b and other programs vital for not-for-profit hospitals.
H.R. 8260 - Hospital Inpatient Services Modernization Act of 2024 - Support for the extension of the Hospital at Home waiver program.
H. R. 7742 - The At HOME Services Act - Support for the current Medicare and Medicaid Hospital at Home programs and the addition of a pilot to support observation level patients at home.
S. 3393 - Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment Reauthorization Act - Support for continuing the national priority to help individuals and families impacted by substance use.
S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023. Support for policies to provide more affordable and accessible health plans.
H.R. 5378 - Lower Costs, More Transparency Act - Issues related to the treatment of 340b and qualified hospitals that serve vulnerable populations.
H.R. 824 - The Telehealth Benefit Expansion for Workers Act of 2023 - Issues related to the continued coverage of telemedicine benefit to increase the reach of coverage for underserved communities.
Issues related to 340b qualified hospitals and ensuring that they are able to best serve vulnerable patients and populations.
Issues related to the implementation of the CMS Hospital at Home waiver, which was continued by the passage of the Consolidated Appropriations Act for FY 2023.
Rules, Regulations and Guidance related to hospitals under the annual prospective payment rules.
Issues related to Medicare and Medicaid DSH
Issues related to developing innovative models of care under the Medicare program.
Issues related to social determinants of health with an emphasis on food as medicine and other anti-hunger and pro-nutrition initiatives.
Issues related to mental and behavioral health care and increasing access to and workforce for patients.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Melanie |
Nathanson |
Ms. |
|
|
Megan |
Hauck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for Medicare, Medicaid and Marketplace coverage.
H.R. 8260 - Hospital Inpatient Services Modernization Act of 2024 - Support for the extension of the Hospital at Home waiver program.
H. R. 7742 - The At HOME Services Act - Support for the current Medicare and Medicaid Hospital at Home programs and the addition of a pilot to support observation level patients at home.
S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023. Support for policies to provide more affordable and accessible health plans.
H.R. 5378 - Lower Costs, More Transparency Act - Issues related to the treatment of 340b and qualified hospitals that serve vulnerable populations.
H.R. 824 - The Telehealth Benefit Expansion for Workers Act of 2023 - Issues related to the continued coverage of telemedicine benefit to increase the reach of coverage for underserved communities.
Issues related to the implementation of the CMS Hospital at Home waiver, which was continued by the passage of the Consolidated Appropriations Act for FY 2023.
Rules, Regulations and Guidance related to hospitals under the annual prospective payment rules.
Issues related to Medicare and Medicaid DSH
Issues related to developing innovative models of care under the Medicare program.
Issues related to mental and behavioral health care and increasing access to and workforce for patients.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Melanie |
Nathanson |
|
|
|
Megan |
Hauck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |